Recommendations for the implementation of the exemptions to the labelling and package leaflet obligations in the centralised pro
european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure en
Another milestone: EURORDIS reviews 100th public document for the European Medicines Agency - EURORDIS
Mock-ups and specimens review
EPF's take on the opportunities and challenges of electronic medicines information
Towards electronic product information for EU medicines Share
EMA'dan Omicron aşılarına yeşil ışık – DW – 01.09.2022
Europe - Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use' - RIS.WORLD
PDF) Consultation on QRD Recommendations on Pack Design and Labelling - response to consultation (EMA/275297/2010) | Theo Raynor - Academia.edu
european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure en
Excipients in the Labelling and Package Leaflet | EMA Guidance
Checking process MUs & SPs (highlighted)
COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
Updates on labelling, package leaflet and variations (EMA) (Feb 2021)
What is a Package Leaflet – How to review it?
Product information: EMA starts digitization - Portolano Cavallo
Epidyolex, INN-cannabidiol
EAHP survey on the future potential of electronic product information (ePI) | European Association of Hospital Pharmacists
Excipients labelling - EMA information - pharma excipients
EMA's QR Code Guidelines—Top Highlights for Pharma Companies
EU Medicines Agency on Twitter: "Always read the package leaflet before taking a #medicine 💊. EMA's decisions can lead to changes in this information. #SafetyOfMedicines 👉https://t.co/7L9uHu1gvO https://t.co/t7ztQPc97M" / Twitter
New | New QRD template released on EMA website
QRD Appendix V Adverse Drug Reaction Reporting Details - en | PDF | Google Play | Pharmacy
EMA updates the guideline on excipients in the labelling and package leaflet of medicinal products
Labelling and package leaflet - YouTube
Evaluation of Tocilizumab as corona artery by the European Medicines Agency( EMA)
Don't Use 'Drugs' to Avoid Mistranslations: EMA Updates Style Guide - Slator
